Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1823565-33-8

Tert-butyl (4-bromo-1,3-benzothiazol-2-yl)carbamate is a chemical compound with the formula C14H16BrN2O2S. It is a carbamate derivative featuring a tert-butyl group attached to a benzothiazole ring, which is substituted with a bromine atom at the 4-position. tert-butyl (4-bromo-1,3-benzothiazol-2-yl)carbamate is known for its diverse chemical functionality and structural features, making it a promising candidate in medicinal chemistry and organic synthesis.

1823565-33-8 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 1823565-33-8 Structure

  • Basic information

    1. Product Name: tert-butyl (4-bromo-1,3-benzothiazol-2-yl)carbamate
    2. Synonyms:
    3. CAS NO:1823565-33-8
    4. Molecular Formula:
    5. Molecular Weight: 329.217
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 1823565-33-8.mol

  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: N/A
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. CAS DataBase Reference: tert-butyl (4-bromo-1,3-benzothiazol-2-yl)carbamate(CAS DataBase Reference)
    10. NIST Chemistry Reference: tert-butyl (4-bromo-1,3-benzothiazol-2-yl)carbamate(1823565-33-8)
    11. EPA Substance Registry System: tert-butyl (4-bromo-1,3-benzothiazol-2-yl)carbamate(1823565-33-8)

  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 1823565-33-8(Hazardous Substances Data)

1823565-33-8 Usage

Uses

Used in Medicinal Chemistry:
Tert-butyl (4-bromo-1,3-benzothiazol-2-yl)carbamate is used as a building block for the synthesis of novel molecules with biological activity. Its unique structure and functional groups allow for the development of new compounds with potential therapeutic applications.
Used in Organic Synthesis:
In the field of organic synthesis, tert-butyl (4-bromo-1,3-benzothiazol-2-yl)carbamate serves as a versatile substrate for further chemical transformations. Its reactivity and steric hindrance provided by the tert-butyl group can be exploited to synthesize a variety of complex organic molecules.
Used in Pharmaceutical Research:
Tert-butyl (4-bromo-1,3-benzothiazol-2-yl)carbamate is used as a starting material in pharmaceutical research to explore its potential as a precursor for the development of new drugs. Its structural features and chemical properties may contribute to the discovery of innovative therapeutic agents.
Used in Chemical Reactivity Studies:
tert-butyl (4-bromo-1,3-benzothiazol-2-yl)carbamate's tert-butyl group and bromine substitution provide opportunities for studying its reactivity with other molecules. This can be valuable in understanding the influence of steric hindrance and electronic effects on chemical reactions, potentially leading to the optimization of synthetic routes and reaction conditions.
Further research is needed to fully explore the potential and properties of tert-butyl (4-bromo-1,3-benzothiazol-2-yl)carbamate in various fields of chemistry and pharmaceuticals, unlocking its full potential for practical applications.

Check Digit Verification of cas no

The CAS Registry Mumber 1823565-33-8 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,8,2,3,5,6 and 5 respectively; the second part has 2 digits, 3 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 1823565-33:
(9*1)+(8*8)+(7*2)+(6*3)+(5*5)+(4*6)+(3*5)+(2*3)+(1*3)=178
178 % 10 = 8
So 1823565-33-8 is a valid CAS Registry Number.

1823565-33-8Relevant articles and documents

HETEROCYCLIC COMPOUNDS AND METHODS OF USE THEREOF

-

Paragraph 0259, (2021/12/28)

The present disclosure relates to inhibitors of one or more isoforms of RAS, such as inhibitors of one or more of KRAS, HRAS and NRAS, or mutants thereof, such as G12D, G12V, G13D or G12C mutants thereof. Therapeutic methods of treating conditions and diseases using these inhibitors are also provided.

HETEROCYCLIC COMPOUNDS AND METHODS OF USE THEREOF

-

Paragraph 0330, (2021/12/28)

The present disclosure relates to inhibitors of one or more isoforms of RAS, such as inhibitors of one or more of KRAS, HRAS and NRAS, or mutants thereof, such as G12D, G12V, G13D or G12C mutants thereof. Therapeutic methods of treating conditions and dis

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1823565-33-8